TMPRSS2 and infection: Additionally, compounds such as nafamostat mesylate, the TMPRSS2 inhibitor, active in Calu-3 but not active in HeLa-ACE2 cells (Figs. 2b and 3a) had the potential to be active in advanced models of infection.